241 blood cancer drugs are in the pipeline

04/29/2013 | Drug Store News

The pipeline of blood cancer treatments in clinical testing or being reviewed by the FDA includes 241 drugs, according to the Pharmaceutical Research and Manufacturers of America. Ninety-eight of the drugs are being developed for the treatment of lymphoma, while 97 are being developed for leukemia, 52 for multiple myeloma and 24 for other cancers of the bone marrow, blood and lymph nodes.

View Full Article in:

Drug Store News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA